Novo Nordisk says FDA rejects applica...

Novo Nordisk says FDA rejects application for approval of long-acting insulin products

Novo Nordisk AS says the Food and Drug Administration rejected its applications for approval of once-per-day insulin drugs to treat diabetes.

Start the conversation, or Read more at Daily News.

More from around the web